Literature DB >> 21674676

Review of cytomegalovirus shedding in bodily fluids and relevance to congenital cytomegalovirus infection.

Michael J Cannon1, Terri B Hyde, D Scott Schmid.   

Abstract

Congenital cytomegalovirus (CMV) infections are a leading cause of sensorineural hearing loss (SNHL) and neurological impairment. Congenital transmission of CMV can occur with maternal primary infection, reactivation, or reinfection during pregnancy. We reviewed studies of CMV shedding in bodily fluids (defined as CMV detected by culture or CMV DNA detected by polymerase chain reaction). Following diagnosis at birth, children with congenital CMV infection exhibited the highest prevalences of CMV shedding (median = 80%, number of sample population prevalences [N] = 6) and duration of shedding, with a steep decline by age five. Healthy children attending day care shed more frequently (median = 23%, N = 24) than healthy children not attending day care (median = 12%, N = 11). Peak shedding prevalences in children occurred at 1-2 years of age, confirming that young children are the key transmission risk for pregnant women. CMV shedding among children was more prevalent in urine specimens than in oral secretions (median prevalence difference = 11.5%, N = 12). Adults with risk factors such as STD clinic attendance had higher shedding prevalences (median = 22%, N = 20) than adults without risk factors (median = 7%, N = 44). In adults with risk factors, CMV was shed more frequently in urine; in adults without risk factors genital shedding was most common. The prevalence of CMV shedding in nine sample populations of pregnant women increased with advancing gestation. In seven sample populations of children with congenital CMV infection, higher viral load at birth was consistently associated with an elevated risk of SNHL. Higher CMV viral load at birth also consistently correlated with the presence of symptoms of congenital CMV at birth. Published 2011. This article is a US Government work and is in the public domain in the USA. Published 2011. This article is a US Government work and is in the public domain in the USA.

Entities:  

Mesh:

Year:  2011        PMID: 21674676      PMCID: PMC4494736          DOI: 10.1002/rmv.695

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


  125 in total

1.  Infectious Diseases Society of America and Centers for Disease Control. Summary of a workshop on surveillance for congenital cytomegalovirus disease.

Authors:  G J Demmler
Journal:  Rev Infect Dis       Date:  1991 Mar-Apr

2.  The molecular epidemiology of cytomegalovirus transmission among children attending a day care center.

Authors:  S P Adler
Journal:  J Infect Dis       Date:  1985-10       Impact factor: 5.226

3.  Epidemiology of Epstein-Barr virus, cytomegalovirus, and Kaposi's sarcoma-associated herpesvirus infections in peripheral blood leukocytes revealed by a multiplex PCR assay.

Authors:  Morie Nishiwaki; Masahiro Fujimuro; Yasuhiro Teishikata; Hisanori Inoue; Hitoshi Sasajima; Kazuhiro Nakaso; Kenji Nakashima; Hidetaka Sadanari; Tomohiro Yamamoto; Yoshie Fujiwara; Naoki Ogawa; Hideyoshi Yokosawa
Journal:  J Med Virol       Date:  2006-12       Impact factor: 2.327

4.  Cytomegalovirus infection anong infants admitted to a paediatric department.

Authors:  H K Andersen; J J Gravesen; T Iversen
Journal:  Acta Paediatr Scand       Date:  1972-07

5.  Isolation of cytomegalovirus and clinical manifestations of infection at different ages.

Authors:  H Stern
Journal:  Br Med J       Date:  1968-03-16

6.  Pathogens in maternal blood and fetal cord blood using Q-PCR assay.

Authors:  Guang Qiong Hou; Sidney S Chen; Chan Ping Lee
Journal:  Taiwan J Obstet Gynecol       Date:  2006-06       Impact factor: 1.705

7.  Infections in preschool children in group day care.

Authors:  K Strangert; G Carlström; S Jeansson; C E Nord
Journal:  Acta Paediatr Scand       Date:  1976-07

8.  Increased rate of cytomegalovirus infection among parents of children attending day-care centers.

Authors:  R F Pass; C Hutto; R Ricks; G A Cloud
Journal:  N Engl J Med       Date:  1986-05-29       Impact factor: 91.245

9.  Detection of cytomegalovirus (CMV) DNA by polymerase chain reaction is associated with hearing loss in newborns with symptomatic congenital CMV infection involving the central nervous system.

Authors:  Russell D Bradford; Gretchen Cloud; Alfred D Lakeman; Suresh Boppana; David W Kimberlin; Richard Jacobs; Gail Demmler; Pablo Sanchez; William Britt; Seng-jaw Soong; Richard J Whitley
Journal:  J Infect Dis       Date:  2004-12-16       Impact factor: 5.226

10.  Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity.

Authors:  S B Boppana; L B Rivera; K B Fowler; M Mach; W J Britt
Journal:  N Engl J Med       Date:  2001-05-03       Impact factor: 91.245

View more
  116 in total

1.  Specialization for Cell-Free or Cell-to-Cell Spread of BAC-Cloned Human Cytomegalovirus Strains Is Determined by Factors beyond the UL128-131 and RL13 Loci.

Authors:  Eric P Schultz; Jean-Marc Lanchy; Le Zhang Day; Qin Yu; Christopher Peterson; Jessica Preece; Brent J Ryckman
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

2.  Natural Inhibitor of Human Cytomegalovirus in Human Seminal Plasma.

Authors:  Sina Lippold; Berenike Braun; Franziska Krüger; Mirja Harms; Janis A Müller; Rüdiger Groß; Jan Münch; Jens von Einem
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

3.  Cytomegalovirus seropositivity is associated with herpes zoster.

Authors:  Benson Ogunjimi; Niel Hens; Richard Pebody; Hilde Jansens; Holly Seale; Mark Quinlivan; Heidi Theeten; Herman Goossens; Judy Breuer; Philippe Beutels
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

4.  Development of a Primary Human Cell Model for the Study of Human Cytomegalovirus Replication and Spread within Salivary Epithelium.

Authors:  Kristen M Morrison; Matthew J Beucler; Emily O Campbell; Margaret A White; Rachel E Boody; Keith C Wilson; William E Miller
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

5.  Longitudinal Kinetics of Cytomegalovirus-Specific T-Cell Immunity and Viral Replication in Infants With Congenital Cytomegalovirus Infection.

Authors:  Sharon F Chen; Tyson H Holmes; Teri Slifer; Vasavi Ramachandran; Sally Mackey; Cathleen Hebson; Ann M Arvin; David B Lewis; Cornelia L Dekker
Journal:  J Pediatric Infect Dis Soc       Date:  2014-09-11       Impact factor: 3.164

Review 6.  Priorities for CMV vaccine development.

Authors:  Philip R Krause; Stephanie R Bialek; Suresh B Boppana; Paul D Griffiths; Catherine A Laughlin; Per Ljungman; Edward S Mocarski; Robert F Pass; Jennifer S Read; Mark R Schleiss; Stanley A Plotkin
Journal:  Vaccine       Date:  2013-10-13       Impact factor: 3.641

7.  The risk of cytomegalovirus infection in daycare workers: a systematic review and meta-analysis.

Authors:  Karla Romero Starke; Marlen Kofahl; Alice Freiberg; Melanie Schubert; Mascha Luisa Groß; Stefanie Schmauder; Janice Hegewald; Daniel Kämpf; Johanna Stranzinger; Albert Nienhaus; Andreas Seidler
Journal:  Int Arch Occup Environ Health       Date:  2019-07-29       Impact factor: 3.015

8.  DNA Polymerase Sequences of New World Monkey Cytomegaloviruses: Another Molecular Marker with Which To Infer Platyrrhini Systematics.

Authors:  Samantha James; Damien Donato; Jean-François Pouliquen; Manuel Ruiz-García; Anne Lavergne; Vincent Lacoste
Journal:  J Virol       Date:  2018-08-29       Impact factor: 5.103

9.  Cytomegalovirus Kinetics Following Primary Infection in Healthy Women.

Authors:  Michael S Forman; Dhananjay Vaidya; Oluwaseyi Bolorunduro; Marie Diener-West; Robert F Pass; Ravit Arav-Boger
Journal:  J Infect Dis       Date:  2017-05-15       Impact factor: 5.226

10.  Characterization of Baboon Cytomegalovirus Infection in Healthy Adult Baboons (Papio anubis).

Authors:  Erin L Willis; Taylor L Stevens; Gary L White; Dianne Mcfarlane
Journal:  Comp Med       Date:  2019-01-31       Impact factor: 0.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.